Dawaa Dost seeks ₹200-250 crore in maiden round to scale generic medicine pharmacy network
Jaipur-based omnichannel generic drug retailer Dawaa Dost is raising its first institutional equity round via EY, targeting ₹200-250 crore to expand offline stores and its Kirana Tech affiliate network across tier-II and tier-III cities.
What happened
Jaipur-based omnichannel generic medicine pharmacy Dawaa Dost seeks to raise ₹200-250 crore in its maiden institutional equity round via EY, to expand its
Key facts
- ₹200-250 crore
- 19,000 pincodes
- 80 offline pharmacies
- $27.3 billion to $42.9 billion pharmacy retail market
- $130 billion pharma market by 2030
Why this matters
Dawaa Dost's EY-led raise and Kirana Tech affiliate model could reshape generic pharmacy distribution in smaller cities, making it worth tracking as a potential partner or competitive threat in your regional expansion plans.
What to watch
- Term sheet signing and lead investor identity
- Same-store sales and gross margin disclosures per city tier
- Kirana Tech affiliate count growth rate
- Competitive moves by Apollo, Netmeds, Tata 1mg in tier-II/III
- Regulatory shifts on generic substitution / Jan Aushadhi expansion
- Announce anchor investor and final round size with valuation
- Sign store-expansion targets tied to specific tier-II/III geographies
- Formalize Kirana Tech affiliate onboarding and supply terms
- Strengthen private-label/generic sourcing and warehousing footprint
- Hire regional ops and pharmacist compliance leadership